JayClydeKoonsMD

Cardiology • Gainesville, FL

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology

Physician

Join to view full profile

Dr. Koons is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Koons' full profile

Already have an account?

Office
1151 NW 64th Ter
Gainesville, FL 32605
Phone+1 352-375-1212

Fax+1 352-371-4650
Is this information wrong?

Education & Training

University of Alabama Medical CenterFellowship, Cardiovascular Disease, 1991 - 1995
University of FloridaResidency, Internal Medicine, 1988 - 1991
University of Maryland School of MedicineClass of 1988

Certifications & Licensure

FL State Medical License 1989 - 2026
AL State Medical License Active through 1995
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification Intergy EHR, Vitera Healthcare Solutions, LLC, 2013
Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

22 citations
Thrombin Decreases the Urokinase Receptor and Surface-Localized Fibrinolysis in Cultured Endothelial Cells
Xin-Nong Li, V. K. Varma, J. M. Parks, Raymond L. Benza, J. C. Koons, J. R. Grammer, Hernan E. Grenett, Edlue M. Tabengwa, Francois M. Booyse> ;Arteriosclerosis, Thrombosis, and Vascular Biology. 1995 Mar 1
In vivo and in vitro dopaminergic effects of three ergoline fragments
Jay C. Koons, John P. Long, Joseph G. Cannon> ;Naunyn-Schmiedeberg's Archives of Pharmacology. 1984 Dec 1
2 citations
Possible biologically active metabolites of 5-hydroxy-6-methyl-2-di-n-propylaminotetralin
Joseph G. Cannon, David C. Furlano, Dale L. Koble, Jay C. Koons, John P. Long> ;Life Sciences. 1984 Apr 23
10 citations
6-Hydroxy-4-[2-(di-n-propylamino)ethyl]indole: synthesis and dopaminergic actions
Joseph G. Cannon, Teresa Lee, Mustafa Ilhan, Jay C. Koons, John P. Long> ;Journal of Medicinal Chemistry. 1984 Mar 1
Hypertriglyceridemic VLDL decreases plasminogen binding to endothelial cells and surface-localized fibrinolysis.
Li, X. N., Koons, J. C., Benza, R. L., Parks, J. M., Varma, V. K., Bradley, W. A., Gianturco, S. H., Taylor, K. B., Grammer, J. R., Tabengwa, E. M., Booyse, F. M.> ;Biochemistry. 1996 May 14
Effects of metyrapone on the pharmacological activity, plasma levels and urinary excretion of the dopamine receptor agonist DK-118.
Koons, J. C., Long, J. P., Koble, D. L., Cannon, J. G., Fischer, L. J.> ;J Pharmacol Exp Ther. 1985 Apr 01
Metabolism and disposition of the dopaminergic agonist 5-hydroxy-6-methyl-2-di-n-propylaminotetralin in the rat.
Koble, D. L., Koons, J. C., Fischer, L. J.> ;Drug Metab Dispos. 1985 May 01
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Member

Hospital Affiliations

HCA Florida Lake City HospitalLake City, Florida
HCA Florida North Florida HospitalGainesville, Florida